Navigation Links
New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer
Date:4/1/2009

DENVER, April 1 /PRNewswire-USNewswire/ -- Responding to President Obama's call for "a cure for cancer in our time," the Pharmaceutical Research and Manufacturers of America (PhRMA) delivered a new report today on medicines in the research pipeline for cancer. The report shows that America's pharmaceutical research and biotechnology companies are testing a record 861 new cancer medicines and vaccines. The medicines listed in the report are being tested in human clinical trials or are awaiting approval by the U.S. Food and Drug Administration.

Nationwide, cancer is the second leading cause of death, affecting more than 10 million Americans, according to the National Cancer Institute. This year, more than half a million Americans are expected to die of cancer -- more than 1,500 a day. In Colorado, the lifetime risk of cancer is 1 in 2 for males and 2 in 5 for females. The most commonly diagnosed cancer in the state is breast cancer, followed by prostate and lung cancer.

"We released this report in Denver because of Colorado's growing role in developing cancer medicines," said PhRMA Senior Vice President Ken Johnson, who unveiled the report at the State Capitol Building.

"Oncology is one of Colorado's core research competencies, so the President's call to cure cancer resonates powerfully in our state," said Colorado Lt. Governor Barbara O'Brien. "We are proud that the cancer medicines now in the research pipeline in Colorado are contributing substantially to the incredible progress made in the last five years by biopharmaceutical companies in developing new and more effective cancer treatments. The nation must continue its strong commitment to the cutting-edge pharmaceutical research that will enable cancer patients to live longer, healthier, and more productive lives."

"I am one of those patients who was diagnosed with cancer and was given a new treatment that brought me from the brink of
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
2. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
3. DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
4. ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform
5. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
6. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
7. Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant
8. Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis
9. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
10. ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimers Disease
11. New Report by BioTrends Research Group to Highlight the Launch of ULORIC(R) (febuxostat)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... -- Ellen MacArthur Foundation meddelade i ... kommer att vara en partner för att hjälpa ... Efter stiftelsens framgångsrika partnerskap med Renault, BT/Cisco ... att ansluta sig som partner för att få ... verksamhet och stödja stiftelsens arbete inom utbildning. ...
(Date:6/19/2013)... , June 19, 2013  Caradigm ... 4.0, a solution designed to help healthcare ... and data while supporting their compliance with ... Provisioning represents a milestone in the delivery ... analytics capabilities for health systems. ...
(Date:6/19/2013)... 19, 2013  Decision Resources, one of the ... and healthcare issues, finds that, for the treatment ... and European rheumatologists cite a therapy,s induction of ... influences their prescribing decisions. Over 60 percent and ... rank the percentage of patients achieving remission at ...
Breaking Medicine Technology:Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 2Ellen MacArthur Foundation presenterar Philips som global partner vid det konstituerande internationella toppmötet om cirkulär ekonomi 3Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2
(Date:6/19/2013)... (PRWEB) June 19, 2013 The Journal ... common with today’s computer software, it creates questions of ... of misconduct. As an already published case shows, scientific ... manipulation. , The Journal of Parasitology features ... in a 2004 article published in the Journal ...
(Date:6/19/2013)... online edition of the journal Nature , a ... California, San Diego School of Medicine visually monitored the ... occurs in zebrafish after cardiac ventricular injury. Their ... heart are more plastic, or capable of transformation into ... the research reveals a novel potential source of cells ...
(Date:6/19/2013)... study reveals significant disparities between minority and white ... treatment programs. Moreover, these disparities vary widely from ... that for most states there,s something amiss," says ... biostatistics. "There are strong racial and ethnic disparities ... abuse treatment programs successfully, and those disparities are ...
(Date:6/19/2013)... -- Nearly 70 percent of Americans are ... than half take two, Mayo Clinic researchers say. ... prescribed, their study found. Twenty percent of patients ... to the findings, published online in the journal ... For audio and video of Dr. Jennifer St. ...
(Date:6/19/2013)... pharmaceutical companies, along with the Japanese government and ... commitment to bolster Japan,s contribution to global health ... Fund), at a press conference held as a ... on African Development (TICAD V). , Representatives from ... of Health, Labour and Welfare, the Ministry of ...
Breaking Medicine News(10 mins):Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 2Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 3
... of moderate iodine deficiency among New Zealanders and mild ... Trans-Tasman regulator// Food Standards Australia New Zealand (FSANZ) to ... salt in some common household products. Recent studies ... getting enough of iodine. ,The proposal by FSANZ ...
... in Malappuram district of Kerala is all set to become ... Class 4-literate//. Some of the credit would go to the ... that village in the age group 15-50 have not passed ... , The Kerala State Literacy Mission has organized the Jyothirgamaya ...
... of the body of a man who died ten years back ... stumbled into a larger racket in trading corpses//. ,The ... of Iftikhar, who died 10 years back after being hit by ... in Malihabad in rural Lucknow. ,The family used to ...
... and Pepsi have challenged on Friday the ban that has ... in separate petitions before the Kerala High Court. ... imposed a limited restriction on the sales of theses drinks ... The Centre for Science and Environment (CSE), which had reported ...
... their eyesight, but according to a recent research, yellow and green ... may be good for the eyesight. ,The diets of 1,700 ... by researchers at the University of Wisconsin to observe the affect ... was carried out by asking each woman what was her regular ...
... British Medical Journal has noted that there has been ... in China.//China now accounts for one fifth of the ... changes in food habits, changes in lifestyle, and reduced ... this problem. ,About 184 million people ...
Cached Medicine News:Health News:Class 4 literacy to be attained by a Kerala village 2Health News:Police Stumble into Trading Corpses Racket 2Health News:Yellow and green vegetables for better eyesight 2
Double ended 1.75 mm by 30 mm sterling silver blade. Flat serrated handle with polished finish....
4 mm wide by 17.5 mm flat platinum spatula on 34 mm shaft. Flat serrated handle with polished finish. Most popular size or model....
... spatula designed to enter a side-port ... to efficiently manipulate the lens nucleus ... useful for rotating and cracking the ... with notch and curved shaft which ...
Double ended lasik spatula with flattened tip for lifting and smoothing the corneal flap. The sharp tip is useful to outline a previous flap in preparation for retreatment....
Medicine Products: